Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Urine Non-invasive Liquid Biopsy in Diagnosis and Recurrence Diagnosis of Urothelial Carcinoma

NCT04994197 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT04994197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04994197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Urine Non-invasive Liquid Biopsy in Diagnosis and Recurrence Diagnosis of Urothelial Carcinoma
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2022
Completion date
August 31, 2024
Enrollment
970 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

urothelial carcinoma